drugset / Trial / NCT02579707

Food Effect Study of AG120 in Healthy Subjects

NCT02579707

Phase 1 Completed 36 enrolled Agios Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This will be a 2-part study. PART 1 is an open-label, randomized, food effect study of AG-120. Subjects will be enrolled to a fed/fasted or fasted/fed treatment sequence in a 2-period crossover design. PART 2 is an open-label study to determine the safety and PK parameters of a single 1000-mg oral dose of AG-120.

Timeline

Start
2015-10
Primary completion
2016-02
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivosidenib Small molecule 1000 mg Oral

Indications

No indication recorded.